Roche Pharmaceuticals Delegation Visits HeYou to Explore New Pathways for Innovative Oncology Treatment Services

On March 12, a delegation from Roche Pharmaceuticals visited HeYou International Hospital Group for an exchange. Li Li, Secretary of the Party Committee and Director of the Management Committee of HeYou International Hospital Group, along with other leaders, warmly received the visiting guests.

The Roche Pharmaceuticals delegation toured the outpatient department, inpatient ward, and pharmacy of HeYou Hospital. During the exchange meeting, Secretary Li Li provided a detailed introduction to HeYou's development history, medical team, advanced equipment, and service philosophy. He stated that HeYou is consistently dedicated to providing patients with high-quality, international medical services, particularly in the field of oncology treatment, where it continuously explores and innovates to bring better treatment outcomes and quality of life to patients.

Li Li, Secretary of the Party Committee and Director of the Management Committee of HeYou International Hospital Group, Delivers a Speech

As a globally leading biopharmaceutical company, Roche Pharmaceuticals covers drug research and development, production, sales, and medical diagnostics, providing patients with breakthrough drugs in key therapeutic areas such as oncology and anti-infection. Qian Wei, General Manager of the Oncology Field for Roche Pharmaceuticals China Customer Interaction Business Model, expressed the expectation to work hand in hand with HeYou to jointly accelerate the development of innovative oncology treatment services.

Roche Pharmaceuticals China Customer Interaction Business Model

——Qian Wei, General Manager of the Oncology Field, Delivers a Speech

That afternoon, both parties also held a roundtable forum themed “What forms of innovative services can help enhance the positive experience of oncology patients?” The forum aimed to explore innovative service models in the field of oncology treatment through in-depth exchange, to further improve patient experience and treatment outcomes.

Lu Jiade, Member of the Management Committee of HeYou International Hospital Group, Vice President of HeYou Hospital, and Head of the Comprehensive Cancer Center, emphasized that HeYou Hospital adheres to medical quality as its core, ensuring alignment with international standards through standardized treatment protocols and MDT multidisciplinary diagnosis and treatment models. Concurrently, the hospital actively introduces commercial insurance and multi-channel payment models to lower patients' financial barriers and enhance accessibility. HeYou Hospital will continue to deepen cooperation with pharmaceutical companies and commercial insurance companies, exploring innovative payment models to jointly promote innovative development in the field of oncology treatment.

Zhai Qing, Director of the Pharmacy Department at HeYou Hospital, discussed from a pharmaceutical professional perspective how innovative hospitals can explore the linker role of oncology pharmacy services. This includes rational drug use based on a clinical demand-oriented drug procurement and supply mechanism, as well as pharmaceutical practices for the scientific and rational use and supervision of anti-tumor drugs.

Zhang Ru, Head of the Hospital Key Account Management Department at Roche Pharmaceuticals China; Shen Shuyi, Head of Clinical Science at Roche Global Drug Development China Center; Pan Lingling, Head of the MCE New Business Unit at Roche Pharmaceuticals; and Hui Ying, Head of Innovative Access in the Market Access Department at Roche Pharmaceuticals, also introduced their respective innovative practices in their fields and expressed expectations for deeper cooperation with HeYou.

This exchange not only deepened mutual understanding and trust between the two parties but also laid a solid foundation for future cooperation. Both parties will take this exchange as an opportunity to further strengthen collaboration in the field of oncology treatment, jointly promote the development of innovative services, and bring hope to more oncology patients.